Ganesh S. Palapattu

9.5k total citations · 1 hit paper
185 papers, 6.5k citations indexed

About

Ganesh S. Palapattu is a scholar working on Pulmonary and Respiratory Medicine, Surgery and Molecular Biology. According to data from OpenAlex, Ganesh S. Palapattu has authored 185 papers receiving a total of 6.5k indexed citations (citations by other indexed papers that have themselves been cited), including 106 papers in Pulmonary and Respiratory Medicine, 59 papers in Surgery and 44 papers in Molecular Biology. Recurrent topics in Ganesh S. Palapattu's work include Prostate Cancer Treatment and Research (71 papers), Prostate Cancer Diagnosis and Treatment (54 papers) and Bladder and Urothelial Cancer Treatments (47 papers). Ganesh S. Palapattu is often cited by papers focused on Prostate Cancer Treatment and Research (71 papers), Prostate Cancer Diagnosis and Treatment (54 papers) and Bladder and Urothelial Cancer Treatments (47 papers). Ganesh S. Palapattu collaborates with scholars based in United States, Austria and Canada. Ganesh S. Palapattu's co-authors include Patrick J. Bastian, Shahrokh F. Shariat, Craig Rogers, Pierre I. Karakiewicz, Seth P. Lerner, Arthur I. Sagalowsky, Yair Lotan, Mark Schoenberg, Amnon Vazina and Bruce J. Trock and has published in prestigious journals such as Journal of Clinical Oncology, PLoS ONE and The Journal of Clinical Endocrinology & Metabolism.

In The Last Decade

Ganesh S. Palapattu

177 papers receiving 6.4k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Outcomes of Radical Cystectomy for Transitional Cell Carcinoma of the Bladder: A Contemporary Series From the Bladder Cancer Research Consortium

2006 509 citations Shahrokh F. Shariat, Pierre I. Karakiewicz et al. The Journal of Urology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Ganesh S. Palapattu United States	41	2.9k	2.7k	1.6k	1.3k	1.1k	185	6.5k
Cheol Kwak South Korea	37	2.4k 0.8×	3.2k 1.2×	1.8k 1.1×	1.4k 1.1×	693 0.6×	435	6.4k
Yoshiyuki Kakehi Japan	44	1.9k 0.7×	2.7k 1.0×	2.7k 1.6×	1.6k 1.3×	677 0.6×	262	7.0k
Armen Aprikian Canada	48	3.0k 1.0×	4.2k 1.6×	2.2k 1.3×	2.0k 1.5×	946 0.9×	279	8.7k
Simon Tanguay Canada	40	2.1k 0.7×	2.4k 0.9×	1.5k 0.9×	816 0.6×	706 0.7×	213	4.7k
Gary D. Grossfeld United States	48	1.9k 0.6×	3.4k 1.3×	1.1k 0.7×	1.4k 1.1×	652 0.6×	123	6.0k
Joel W. Slaton United States	42	1.9k 0.7×	1.6k 0.6×	2.5k 1.5×	1.6k 1.3×	656 0.6×	118	6.0k
C.C. Abbou France	40	2.3k 0.8×	2.5k 0.9×	2.0k 1.2×	678 0.5×	521 0.5×	139	5.0k
Thierry Lebrét France	39	3.8k 1.3×	1.8k 0.7×	1.5k 0.9×	936 0.7×	2.0k 1.8×	269	6.6k
Sergio Serni Italy	40	1.4k 0.5×	3.1k 1.2×	2.0k 1.2×	1.5k 1.2×	1.6k 1.5×	247	7.0k
Karim Chamie United States	34	2.5k 0.9×	1.7k 0.6×	1.4k 0.8×	1.3k 1.0×	583 0.5×	183	5.1k

Countries citing papers authored by Ganesh S. Palapattu

Since Specialization

Citations

This map shows the geographic impact of Ganesh S. Palapattu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ganesh S. Palapattu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ganesh S. Palapattu more than expected).

Fields of papers citing papers by Ganesh S. Palapattu

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ganesh S. Palapattu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ganesh S. Palapattu. The network helps show where Ganesh S. Palapattu may publish in the future.

Co-authorship network of co-authors of Ganesh S. Palapattu

This figure shows the co-authorship network connecting the top 25 collaborators of Ganesh S. Palapattu. A scholar is included among the top collaborators of Ganesh S. Palapattu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ganesh S. Palapattu. Ganesh S. Palapattu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Patel, Parth, David Scoville, Brittney Cotta, et al.. (2024). Spatial Transcriptomic Profiling to Characterize the Nature of Peripheral- Versus Transition-zone Prostate Cancer. European Urology Focus. 11(2). 226–234. 3 indexed citations

Schaub, Jennifer A., Christopher L. O’Connor, Yurui Chang, et al.. (2023). Spatial Heterogeneity of Glomerular Phenotypes Affects Kidney Biopsy Findings. Kidney360. 4(11). 1598–1607. 4 indexed citations

Vince, Randy, Brittney Cotta, Judith Stangl‐Kremser, et al.. (2023). Analysis of the Tumor Immune Microenvironment (TIME) in Clear Cell Renal Cell Carcinoma (ccRCC) Reveals an M0 Macrophage-Enriched Subtype: An Exploration of Prognostic and Biological Characteristics of This Immune Phenotype. Cancers. 15(23). 5530–5530. 7 indexed citations

Cotta, Brittney, Toni K. Choueiri, Marcin Cieślik, et al.. (2023). Current Landscape of Genomic Biomarkers in Clear Cell Renal Cell Carcinoma. European Urology. 84(2). 166–175. 39 indexed citations

Tosoian, Jeffrey J., Bruce J. Trock, Ashley E. Ross, et al.. (2022). MyProstateScore in men considering repeat biopsy: validation of a simple testing approach. Prostate Cancer and Prostatic Diseases. 26(3). 563–567. 6 indexed citations

Vince, Randy, Judith Stangl‐Kremser, Daniel Triner, et al.. (2021). 692P Characterization of the tumor immune microenvironment in early-stage clear cell renal cell carcinoma (ccRCC): Prognostic value of an M0-macrophage enriched subtype. Annals of Oncology. 32. S707–S707. 1 indexed citations

Singhal, Udit, Yugang Wang, James Henderson, et al.. (2018). Multigene Profiling of CTCs in mCRPC Identifies a Clinically Relevant Prognostic Signature. Molecular Cancer Research. 16(4). 643–654. 27 indexed citations

Russell, Christopher, Amir H. Lebastchi, Juan Chipollini, et al.. (2018). Multi-institutional Survival Analysis of Incidental Pathologic T3a Upstaging in Clinical T1 Renal Cell Carcinoma Following Partial Nephrectomy. Urology. 117. 95–100. 29 indexed citations

Hovelson, Daniel H., Simpa S. Salami, Jeremy Kaplan, et al.. (2018). Integrative molecular profiling challenges robustness of prognostic signature scores in multifocal prostate cancer.. Journal of Clinical Oncology. 36(6_suppl). 96–96. 3 indexed citations

10.

Brand, Lucas J., et al.. (2017). Abstract LB-185: A PSMA-directed natural killer cell approach for prostate cancer immunotherapy. Cancer Research. 77(13_Supplement). LB–185. 1 indexed citations

11.

Palapattu, Ganesh S., Simpa S. Salami, Andi K. Cani, et al.. (2016). Molecular Profiling to Determine Clonality of Serial Magnetic Resonance Imaging/Ultrasound Fusion Biopsies from Men on Active Surveillance for Low-Risk Prostate Cancer. Clinical Cancer Research. 23(4). 985–991. 17 indexed citations

12.

Johnson, Skyler B., Will Jackson, Corey C. Foster, et al.. (2013). The Interval to Biochemical Failure Is Prognostic for Metastasis, Prostate Cancer-Specific, and Overall Mortality Following Salvage Radiation Therapy for Prostate Cancer. International Journal of Radiation Oncology*Biology*Physics. 87(2). S396–S396. 1 indexed citations

13.

Kaushik, Akash, Shaiju K. Vareed, Sumanta Basu, et al.. (2013). Metabolomic Profiling Identifies Biochemical Pathways Associated with Castration-Resistant Prostate Cancer. Journal of Proteome Research. 13(2). 1088–1100. 48 indexed citations

14.

Sonpavde, Guru & Ganesh S. Palapattu. (2010). Neoadjuvant therapy preceding prostatectomy for prostate cancer: rationale and current trials. Expert Review of Anticancer Therapy. 10(3). 439–450. 4 indexed citations

15.

Simon, Rochelle A., Paul A. di Sant'Agnese, Li‐Shan Huang, et al.. (2008). CD44 expression is a feature of prostatic small cell Carcinoma and Distinguishes it from its Mimickers. Human Pathology. 40(2). 252–258. 60 indexed citations

16.

Shariat, Shahrokh F., Ganesh S. Palapattu, Pierre I. Karakiewicz, et al.. (2006). Discrepancy between Clinical and Pathologic Stage: Impact on Prognosis after Radical Cystectomy. European Urology. 51(1). 137–151. 267 indexed citations

17.

Lotan, Yair, Amit Gupta, Shahrokh F. Shariat, et al.. (2005). Lymphovascular Invasion Is Independently Associated With Overall Survival, Cause-Specific Survival, and Local and Distant Recurrence in Patients With Negative Lymph Nodes at Radical Cystectomy. Journal of Clinical Oncology. 23(27). 6533–6539. 228 indexed citations

18.

Palapattu, Ganesh S., Mohamad E. Allaf, Bruce J. Trock, Jonathan I. Epstein, & Patrick C. Walsh. (2004). PROSTATE SPECIFIC ANTIGEN PROGRESSION IN MEN WITH LYMPH NODE METASTASES FOLLOWING RADICAL PROSTATECTOMY: RESULTS OF LONG-TERM FOLLOWUP. The Journal of Urology. 172(5). 1860–1864. 98 indexed citations

19.

Palapattu, Ganesh S., Hyung L. Kim, & Arie S. Belldegrun. (2003). Lymph node dissection in patients with kidney cancer: when is it indicated?. PubMed. 5(3). 196–9. 2 indexed citations

20.

Palapattu, Ganesh S., Blaine Kristo, & Jacob Rajfer. (2002). Paraneoplastic syndromes in urologic malignancy: the many faces of renal cell carcinoma.. PubMed. 4(4). 163–70. 117 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact